St. Jude Medical (STJ) Announces First U.S. Patient Implant Of Non-Surgical, Leadless Cardiac Pacemaker
2/6/2014 8:35:42 AM
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the first U.S. implant in the company’s LEADLESS II pivotal trial designed to evaluate the Nanostim™ leadless pacemaker for U.S. Food and Drug Administration (FDA) approval. The world’s first retrievable, non-surgical pacemaker was implanted at The Mount Sinai Hospital in New York City by Dr. Vivek Reddy.
Help employers find you! Check out all the jobs and post your resume.
comments powered by